original ) (raw )Detection of anti-Saccharomyces cerevisiae antibodies in Crohn's disease: is it reliable diagnostic and prognostic marker?
Marco Astegiano
Digestive and Liver Disease, 2001
View PDFchevron_right
Anti-Saccharomyces cerevisiae mannan antibodies in familial Crohn's disease
mian manan
The American journal …, 1998
View PDFchevron_right
Antibodies to Saccharomyces cerevisiae in Crohnʼs disease
Monica Talor
Inflammatory Bowel Diseases, 2007
View PDFchevron_right
Combination of genetic and quantitative serological immune markers are associated with complicated Crohnʼs disease behavior
Emil Chuang
Inflammatory Bowel Diseases, 2011
View PDFchevron_right
Anti-Saccharomyces cerevisiae Antibodies in Patients with Inflammatory Bowel Disease and Their First-Degree Relatives: Potential Clinical Value
yosra thabet
Digestion, 2002
View PDFchevron_right
Diagnosis and assessment of Crohns disease: The present and the future
Giovanni Terrosu
Expert Review of Gastroenterology and Hepatology, 2010
View PDFchevron_right
European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis
N. Mortensen
Gut, 2006
View PDFchevron_right
Differential diagnosis of Crohn’s disease using antibodies to glycoprotein 2 and Saccharomyces cerevisiae
Sadettin Hulagu
The Turkish Journal of Gastroenterology
View PDFchevron_right
A simple classification of Crohn's disease: Report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998
David Sachar
Inflammatory Bowel Diseases, 2007
View PDFchevron_right
Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease
Itamar Grotto
Gut, 2005
View PDFchevron_right
A laboratory index for predicting relapse in asymptomatic patients with Crohn's disease
Patrizia Farruggia
Gastroenterology, 1986
View PDFchevron_right
Behaviour of Crohn's disease according to the Vienna classification
David Sachar
Gut, 2002
View PDFchevron_right
Diagnosis and classification of Crohn's disease
Dirk Roggenbuck
Autoimmunity Reviews, 2014
View PDFchevron_right
Seroreactivities against Saccharomyces cerevisiae and Mycobacterium avium subsp. paratuberculosis p35 and p36 antigens in Crohn's disease patients
Ira Shafran
Digestive diseases and sciences, 2002
View PDFchevron_right
Significance of anti-sacharomices cerevisiae antibodies (ASCA) in patients with inflammatory bowel diseases in Romania
Carmen Preda
Romanian journal of gastroenterology, 2005
View PDFchevron_right
Anti-Saccharomyces cerevisiae mannan antibodies in inflammatory bowel disease: comparison of different assays and correlation with clinical features
Daniel Poulain
Alimentary Pharmacology and Therapeutics, 2004
View PDFchevron_right
Antibodies anti-Saccharomyces cerevisiae (ASCA) do not differentiate Crohn's disease from celiac disease
Petra Theiss
Arquivos de Gastroenterologia, 2010
View PDFchevron_right
Effects of Disease Activity on Anti–Saccharomyces cerevisiae Antibodies
Salvatore Cucchiara
Inflammatory Bowel Diseases, 2004
View PDFchevron_right
Utility of fecal and serum anti-Saccharomyces cerevisiae antibodies in the diagnosis of Crohn’s disease-like condition of the pouch
Lauren Frederica Moore
International Journal of Colorectal Disease, 2012
View PDFchevron_right
Diagnostic Precision of Anti-Saccharomyces cerevisiae Antibodies and Perinuclear Antineutrophil Cytoplasmic Antibodies in Inflammatory Bowel Disease
Constantinos Simillis , Vasilis Constantinides
The American Journal of Gastroenterology, 2006
View PDFchevron_right
Relationship between clinical features of Crohn's disease and the risk of developing extraintestinal manifestations
J.enrique Domínguez-muñoz
European journal of …, 2007
View PDFchevron_right
Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role
Daniel Panca
Gut, 1998
View PDFchevron_right
Anti-Saccharomyces cerevisiae antibodies (ASCA) in Crohn's disease are associated with disease severity but not NOD2/CARD15 mutations
Paolo Muratori , Haner Direskeneli
Clinical and Experimental Immunology, 2004
View PDFchevron_right
P704 Do antiglycan antibodies have an impact on the course of Crohn's disease?
Bulent Baban
Journal of Crohn's and Colitis, 2013
View PDFchevron_right
Association between intestinal permeability and anti-Saccharomyces cerevisiae antibodies in patients with Crohnʼs disease
Govind Makharia
Inflammatory Bowel Diseases, 2008
View PDFchevron_right
Targeting Tissular Immune Response Improves Diagnostic Performance of Anti-Saccharomyces cerevisiae Antibodies (ASCA) in Crohn’s Disease
Ariadne Desjeux
PLoS ONE, 2013
View PDFchevron_right
Genetic and serological markers to identify phenotypic subgroups in a Dutch Crohn’s disease population
Amado Salvador Peña
Digestive and Liver Disease, 2004
View PDFchevron_right